Krishna Kant Sharma

Krishna Kant Sharma

Auto-generated profile, based on publicly available information

Krishna Kant Sharma

Maharshi Dayanand University

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2020 in Letters in Applied Microbiology
Verified
Journal Article
Open access
PDF file
SAShruti Ahlawat
Shruti Ahlawat
ASAsha
Asha
KSKrishna Kant Sharma
Krishna Kant Sharma
Human gut microbiota (GM) includes a complex and dynamic population of microorganisms that are crucial for well‐being and survival of the organism. It has been reported as diverse and relatively stable with shared core microbiota, including Bacteroidetes and Firmicutes as the major dominants. They are the key regulators of body homeostasis, involving both intestinal and extra‐intestinal effects by influencing many physiological functions such as metabolism, maintenance of barrier homeostasis, inflammation, and hematopoiesis. Any alteration in GM community structures not only trigger gut disorders, but also influence other organs and cause associated diseases. In recent past, the GM has been defined as a “vital organ” with its involvement with other organs; thus, establishing a link or a bi‐ or multi‐directional communication axis between the organs via neural, endocrine, immune, humoral, and metabolic pathways. Alterations in GM have been linked to several diseases known to humans; although the exact interaction mechanism between the gut and the organs is yet to be defined. In this review, the bi‐directional relationship between the gut and the vital human organs was envisaged and discussed under several headings. Furthermore, several disease symptoms were also re‐visited to re‐define the communication network between the gut microbes and the associated organs.

28 August 2019 in Critical Reviews in Food Science and Nutrition
Verified
Journal Article
Closed access
NENeelam
Neelam
AKAnurag Khatkar
Anurag Khatkar
KSKrishna Kant Sharma
Krishna Kant Sharma
Phenylpropanoids and their derivatives are plant secondary metabolites widely present in fruits, vegetables, cereal grains, beverages, spices and herbs. They are known to have multifaceted effects which include antimicrobial, antioxidant, anti-inflammatory, antidiabetic, anticancer activities and as well as exhibits renoprotective, neuroprotective, cardioprotective and hepatoprotective effects. Owing to their antioxidant, antimicrobial and photoprotective properties, these compounds have wide application in the food (preservation, packaging films and edible coating), pharmaceutical, cosmetic and other industries such as textile (colorant), biofuel (antioxidant additive) and sensors (sensing biologically relevant molecules). Phenylpropanoids are present in commercially available dietary supplements and skin care products. In this review, we have presented the current knowledge on the biosynthesis, occurrence, biological activities of phenylpropanoids and their derivatives, along with the mechanism of action and their potential applications in various industries.

1 December 2021 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
SSSonu Saini
Sonu Saini
KSKrishna Kant Sharma
Krishna Kant Sharma

1 September 2020 in Virus Research
Verified
Journal Article
Closed access
SAShruti Ahlawat
Shruti Ahlawat
ASAsha
Asha
KSKrishna Kant Sharma
Krishna Kant Sharma

12 February 2021 in Critical Reviews in Microbiology
Verified
Journal Article
Closed access
SAShruti Ahlawat
Shruti Ahlawat
PKPramod Kumar
Pramod Kumar
HMHari Mohan
Hari Mohan
SGSandeep Goyal
Sandeep Goyal
KSKrishna Kant Sharma
Krishna Kant Sharma
Human gut microbiota contributes to host nutrition and metabolism, sustains intestinal cell proliferation and differentiation, and modulates host immune system. The alterations in their composition lead to severe gut disorders, including inflammatory bowel disease (IBD) or inflammatory bowel syndrome (IBS). IBD including ulcerative colitis (UC) and Crohn’s disease (CD) are gamut of chronic inflammatory disorders of gut, mediated by complex interrelations among genetic, environmental, and internal factors. IBD has debateable aetiology, however in recent years, exploring the central role of a tri-directional relationship between gut microbiota, mucosal immune system, and intestinal epithelium in pathogenesis is getting the most attention. Increasing incidences and early onset explains the exponential rise in IBD burden on health-care systems. Industrialization, hypersensitivity to allergens, lifestyle, hygiene hypothesis, loss of intestinal worms, and gut microbial composition, explains this shifted rise. Hitherto, the interventions modulating gut microbiota composition, microfluidics-based in vitro gastrointestinal models, non-allergic functional foods, nutraceuticals, and faecal microbiota transplantation (FMT) from healthy donors are some of the futuristic approaches for the disease management.

12 May 2022 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
ASAkshay Shankar
Akshay Shankar
KSKrishna Kant Sharma
Krishna Kant Sharma